Another TCP-based LSD1/MAO-B dual inhibitor, vafidemstat (ORY-2001), is in clinical trial for Alzheimer’s diseases and personality disorders. The gene discussed is KDM1A; the disease is early-onset autosomal dominant Alzheimer disease.